Position in LLY
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$1,494,489
+$444,112 QoQ
Shares Held
1,246
+9.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#2,766
of 4,601 holders
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ALBION FINANCIAL GROUP /UT holds $22,152,027 across 13 Drug Manufacturers - General names. LLY ranks #5 (6.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
24,267 | $8,787,566 | |
| 2 | ABBV |
AbbVie Inc.
|
18,850 | $4,743,414 | |
| 3 | MRK |
Merck & Co., Inc.
|
30,544 | $3,924,904 | |
| 4 | JNJ |
Johnson & Johnson
|
11,083 | $2,814,749 | |
| 5 | LLY |
ELI LILLY & Co
This page
|
1,246 | $1,494,489 | |
| 6 | PFE |
Pfizer Inc
|
7,059 | $169,980 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
577 | $72,898 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
800 | $46,096 |
All Filings in LLY
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,494,489 | 1,246 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $1,050,377 | 1,142 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $1,200,417 | 1,117 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $898,051 | 1,177 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $910,491 | 1,168 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $952,274 | 1,153 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $890,116 | 1,153 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $997,568 | 1,126 | Shares | Sole | 2024-10-09 | |
| 2024-06-30 | $1,019,457 | 1,126 | Shares | Sole | 2024-07-10 | |
| 2024-03-31 | $875,982 | 1,126 | Shares | Sole | 2024-04-19 | |
| 2023-12-31 | $659,865 | 1,132 | Shares | Sole | 2024-01-26 | |
| 2023-09-30 | $609,642 | 1,135 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $528,071 | 1,126 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $351,662 | 1,024 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $380,107 | 1,039 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $339,194 | 1,049 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $340,117 | 1,049 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $300,402 | 1,049 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $296,384 | 1,073 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $236,826 | 1,025 | Shares | Sole | 2021-10-19 | |
| 2021-06-30 | $235,258 | 1,025 | Shares | Sole | 2021-08-12 | |
| 2020-12-31 | $173,061 | 1,025 | Shares | Sole | 2021-02-19 | |
| No filing history on record for this holder in this stock. | ||||||